Workflow
Rocket Pharmaceuticals (RCKT) Investor Presentation - Slideshow

| --- | --- | |---------------|--------------------------------------------------------| | | | | INVESTOR DECK | INVESTOR DECK INVESTOR DECK SEEKING GENE THERAPY CURES | | | | DISCLAIMER regarding its guidance for 2022 in light of COVID-19, the safety, effectiveness and timing of product candidates that Rocket may develop, to treat Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), Pyruvate Kinase Deficiency (PKD), and Danon Disease, and the safety, effectiveness and timing of related pre-clinica ...